Estimates Revisions Forte Biosciences, Inc.
Stocks
FBRX
US34962G2084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.70 USD | +5.42% |
|
+35.22% | +118.92% |
| 07-21 | Barclays Initiates Forte Biosciences at Overweight With $74 Price Target | MT |
| 07-09 | Forte Biosciences, Inc. - Special Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- FBRX Stock
- Consensus Forte Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
